Early steroid withdrawal in repeat kidney transplantation

Area of Science:

• Nephrology
• Transplantation Immunology
• Immunosuppression Therapy

Background:

• Kidney re-transplantation (KRT) candidates face high graft failure risks.
• Chronic steroid maintenance (CSM) is standard for KRT patients.
• Safety of early steroid withdrawal (ESW) in KRT is not well-established.

Purpose of the Study:

• To compare outcomes of ESW versus CSM in KRT recipients.
• To evaluate patient survival, graft survival, and graft function.
• To assess the incidence of adverse events associated with each regimen.

Main Methods:

• Retrospective analysis of 113 KRT patients.
• Groups: ESW (n=59) and CSM (n=54).
• All patients received induction therapy and were maintained on mycophenolate/tacrolimus.

Main Results:

• No significant differences in 1- and 5-year patient or graft survival between ESW and CSM groups.
• Comparable estimated GFR at 1 and 5 years between groups.
• CSM group had higher rates of hyperlipidemia, osteoporosis, post-transplant diabetes, and hypertension requiring more medications.

Conclusions:

• ESW is a viable immunosuppression strategy for KRT recipients.
• ESW demonstrates comparable short- and intermediate-term outcomes to CSM.
• ESW may reduce the incidence of steroid-related comorbidities.